Navidea Biopharmaceuticals has formed a partnership with Maimonides Medical Center in New York that will focus on an open-label clinical trial involving Lymphoseek, a radiopharmaceutical designed to stage cancers by pinpointing the lymph nodes that drain from a primary tumor. The trial will test the agent in patients with colorectal cancer and is set to start in the first half of the year.
Health organizations have defined healthy bacteria or probiotics, but there is little scientific evidence supporting many of the health claims associated with them. Food labels may not clearly spell out what type of probiotic a product contains or what health benefits it might have, and regulatory agencies worldwide are looking at reining in the industry.
A study found 64% of patients diagnosed with ulcerative colitis after age 50 were in remission after one year compared with 49% of those who developed UC at younger ages, according to researchers from Washington University in St. Louis. "Younger patients are more likely to have robust inflammatory responses, so their disease is harder to quiet down," the study's lead researcher said.
ABC's "Boston Med" show featured the story of retired firefighter Tom Alden's battle against Stage III colon cancer, including surgery and chemotherapy. He said the diagnosis hit him "like a ton of bricks" even though he always suspected he would get cancer one day because of all the smoke he was exposed to over the years.
A Wayne, Mich., woman is happy to spend the holidays with her family this year after battling a rare genetic-based colorectal cancer that claimed the life of her mother, grandmother and sister, all before age 50. Unlike her relatives, newer treatments have given Patricia Kraus, who has with Lynch syndrome, a good chance for a full recovery.